Figure 4.
Cumulative survival rates. A: According to the pre-treatment α-fetoprotein (AFP) level; B: According to the AFP reduction after two cycles of hepatic arterial infusion chemotherapy (HAIC); C: According to the pre-treatment protein induced by vitamin K absence or antagonist (PIVKA)-II level; D: According to the PIVKA-II reduction after two cycles of HAIC.